Miller Oncology Lectures Flashcards
Malignant bone lesions seen in age < 5
LCH (Letter-Siwe), LCH (Hand-Schuller-Christian), metastatic rhabdomyosarcom, metastatic neuroblastoma
Malignant bone lesions seen age 5-30
Ewing’s, osteosarcoma
Malignant bone lesions seen age >30
Chondrosarcoma, (BPKLT) metastases, lymphoma, myeloma, chordoma, adamantinoma
Benign bone lesions seen in age <5
Osteomyelitis, osteofibrous dysplasia
Benign bone lesions seen in age 5-30
Osteoid osteoma, osteoblastoma, chondroblastoma, ABC, LCH, osteofibrous dysplasia, NOF
Benign bone lesions seen in age >30
Giant cell, Pagets
t(11;22)
Ewing’s
t(X;18), SSX1-SYT
Synovial sarcoma
Rb and p53
Osteosarcoma
Soft tissue sarcomas that are treated with chemotherapy
Synovial sarcoma and rhabdomyosarcoma. Otherwise, other soft tissue sarcomas are treated with XRT and surgery only.
Sarcomas treated with chemo, surgery, chemo
Ewing’s sarcoma, intramedullary and periosteal osteosarcoma
Tumors treated with ORIF and XRT
Mets (BPKLT), myeloma and lymphoma
Tumors treated with intralesional resection
GCT, ABC, NOF, LCH, osteoblastoma, chondroblastoma
Tumor treated with RFA
osteoid osteoma that has failed NSAIDs
Tumors treated with wide excision and limb salvage
Chondrosarcoma, adamantinoma, chordoma, parosteal osteosarcoma and soft tissue sarcoma
Cardiotoxic chemo drug used for osteosarcoma and Ewing’s sarcoma
Doxorubicin
35 year old patient with history of Ewing’s treated with chemotherapy presents with fatigue, gum bleeding and bruising. What’s his diagnosis?
Post-chemotherapy leukemia, confirm with CBC with peripheral blood smear
Palliative XRT dose for mets
25-30 Gy
Pre-op XRT dose for soft tissue sarcoma, associated complications
50 Gy, perioperative wound healing complications
Post-op XRT dose for soft tissue sarcoma, associated complications
60 Gy, fibrosis, bone necrosis and fracture complications
HO prophylaxis XRT dose
5 Gy
Diaphyseal bone lesions
AEIOUY - Adamantinoma, eosinophilic granuloma, infection, osteoid osteoma/osteoblastoma, “U”-wings sarcoma, fYbrous dysplasia, lYmphoma, mYeloma
Top 2 locations for bony metastases
1) Spine via Batson’s plexus 2) Proximal femur
Enneking’s 4 questions
Location, what’s the tumor doing to the bone, what’s the bone doing to the tumor, what is the matrix of the lesion
Common epiphyseal tumors
Chondroblastoma (skeletally immature), giant cell and clear cell chondrosarcoma (femoral head)
Common epiphyseal tumors
Chondroblastoma (skeletally immature), giant cell, clear cell (femoral head)
Common metaphyseal tumors
Osteosarcoma, chondrosarcoma and metastases (BPKTL)
Common anterior spine tumors? Posterior?
Anterior = giant cell and mets. Posterior = osteoid osteoma, osteoblastoma and ABC
Common sacral lesions
ABC, giant cell, chordoma (shown), mets
Common flat bone lesions
Hemangioma, fibrous dysplasia, chondrosarcoma, Paget’s, Ewing’s, mets
Common tibial lesions
Chondromyxoid fibroma (shark bite in proximal medial tibia), non-ossifying fibroma (soap bubbles) and adamantinoma (cortical lesions up and down diaphysis)
Chondromyxoid fibroma histology
Chondroid matrix, myxoid matrix and fibrous matrix
Non-ossifying fibroma histology
Mostly fibrous tissue
Adamantinoma histology
Nests and glands in the bone
Common intracortical lesions
Osteomyelitis, osteoid osteoma, osteoblastoma, osteofibrous dysplasia and adamantinoma
Brown tumor
Multiple lytic bone lesions from hyperparathyroidism
Systemic staging
CT C/A/P (only chest if sarcoma), whole body bone scan (skeletal survey if Myeloma) +/- PET, bone marrow bx in Ewing’s and Myeloma
Note that SPEP/UPEP are used for diagnosis of myeloma, not staging
Cold bone scan lesions
Myeloma, renal cell and thyroid, these turn over too quickly to be caught on bone scan
SUV that identifies malignancy
2.0
Biopsy principles
Longitudinal incision in line with future resection, avoid critical neurovascular structures, preferentially biopsy soft tissue over bone to not weaken the bone, strict hemostasis
Indications for incisional vs excisional biopsy
Mass >3cm (1.5 in hand/foot) and unsure of diagnosis = incisional, any smaller = excisional
3 cell lineage tumor origins
Parenchymal = organs = carcinoma
Hematopoietic = lymphatic/bone = myeloma, leukemia
Mesenchymal = connective tissue = sarcoma
Synovial chondromatosis is an example of ___
Metaplasia, the irritated synovial tissue has changed to produce small cartilagenous bodies
What is this?
Normal bone. Note the flat blue osteoblasts making woven bone that matures into lamellar bone and intervening fat.
What is this?
Normal cartilage. Note the plump chondrocytes with double lacuna and bluish color.
Small round blue cell tumors
“LERNM” - Lymphoma, Ewing’s, Rhabdomyosarcoma, Neuroblastoma, Myeloma
Lymphoma lab markers
CD45+, leukocyte common antigen (LCA+)
Ewing’s lab markers
t(11;22), EWS-FLI-1, Vimentin+, Keratin+, CD99+, pseudorosettes on path
Rhabdomyosarcoma lab marker
Desmin+ (shown), t(2;13), PAX-FKHR
Neuroblastoma lab marker
Neuron specific enolase (NSE+), NB84
Myeloma lab markers
Monoclonal spike on SPEP/UPEP, monoclonal immunoreactivity for kappa or lambda light chain, CD 20+, plasma cells with clock faced nuclei
Tumors with giant cells
Giant cells are large osteoclasts seen in many tumors.
ABC, chondroblastoma, chondromyxoid fibroma, giant cell tumor of tendon sheath, giant cell tumor and giant cell rich osteosarcoma.
In giant cell tumor of bone, the stroma cells look the same as the cells within the giant cell (shown).
Diagnosis?
Giant cells in chondroblastoma, notice the fried egg, cobblestone, chicken wire calcifications next to the giant cells, indicating chondroblastoma
Leiomyosarcoma immunohistochemistry
Smooth muscle actin (SMA)
MPNST and Schwannoma immunohistochemistry
S-100, neural origin
Hemangioma, hemangioendothelioma and angiosarcoma immunohistochemistry
CD31 and CD34, endothelial origin
Fibromatosis (extra-abdominal desmoid) immunohistochemistry
Beta-catenin
Ewing’s/PNET immunohistochemistry
CD 99
Epithelioid sarcoma immunohistochemistry
Loss of INI 1
Epithelioid sarcoma, synovial sarcoma and carcinoma immunohistochemistry
Keratin +
Epithelioid and synovial sarcoma immunohistochemistry
Epithelial membrane antigen (EMA)
Rhabdomyosarcoma immunohistochemistry
MyoD1, myogenin (Myf-4)
Soft tissue sarcoma immunohistochemistry
Vimentin+
Chromosomal translocation for:
Ewing’s/PNET
Myxoid liposarcoma
Alveolar rhabodomyosarcoma
Clear cell sarcoma
Synovial sarcoma
Myxoid chondrosarcoma